146 related articles for article (PubMed ID: 10451795)
41. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
42. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.
Van Nerom CG; Bormans GM; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Sep; 20(9):738-46. PubMed ID: 8223766
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.
Pavía J; Ros D; Piera C; Pavía A; Bassa P; Giralt E; Setoain J
Nucl Med Commun; 1991 Jun; 12(6):529-37. PubMed ID: 1830943
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
45. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Stabin M; Taylor A; Eshima D; Wooter W
J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
[TBL] [Abstract][Full Text] [Related]
46. 99mTc-MAG3: dynamic studies in patients with renal disease.
Schaap GH; Alferink TH; de Jong RB; Oe PL; Roos JC; Donker AJ
Eur J Nucl Med; 1988; 14(1):28-31. PubMed ID: 2968259
[TBL] [Abstract][Full Text] [Related]
47. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
49. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
50. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
51. Usefulness of 99Tcm-N,N'-ethylene-1-dicysteine complex for dynamic kidney investigations.
Surma MJ; Wiewióra J; Liniecki J
Nucl Med Commun; 1994 Aug; 15(8):628-35. PubMed ID: 7970444
[TBL] [Abstract][Full Text] [Related]
52. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
53. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of effective renal plasma flow with I-127 ortho-iodohippurate and I-123 ortho-iodohippurate in rabbits.
Mariani G; Augeri C; Pretolesi F; Mereto E; Curti G; Martinoli C; Martelli A; Derchi LE
Acad Radiol; 2000 Sep; 7(9):705-10. PubMed ID: 10987332
[TBL] [Abstract][Full Text] [Related]
55. Effect of sample number and time on determination of plasma clearance of technetium Tc 99m pentetate and orthoiodohippurate sodium I 131 in dogs and cats.
Barthez PY; Chew DJ; DiBartola SP
Am J Vet Res; 2000 Mar; 61(3):280-5. PubMed ID: 10714519
[TBL] [Abstract][Full Text] [Related]
56. Prospective validation of single plasma sample 99mTc-ethylenedicysteine clearance in adults.
Kabasakal L; Halaç M; Yapar AF; Alkan E; Kanmaz B; Onsel C; Sönmezoğlu K; Ayaz M; Kalender B; Sayman HB; Uslu I
J Nucl Med; 1999 Mar; 40(3):429-31. PubMed ID: 10086707
[TBL] [Abstract][Full Text] [Related]
57. Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH.
Stadalnik RC; Vogel JM; Jansholt AL; Krohn KA; Matolo NM; Lagunas-Solar MC; Zielinski FW
J Nucl Med; 1980 Feb; 21(2):168-70. PubMed ID: 7356755
[TBL] [Abstract][Full Text] [Related]
58. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
[TBL] [Abstract][Full Text] [Related]
59. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
